SCHEMBL441387

SCHEMBL441387

C=C(C)C(=O)NCCCCCCC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
HIF1A Q16665 1/20 0.43
EPHX1 P07099 4/20 0.40
ANPEP P15144 2/20 0.39
RNPEP Q9H4A4 2/20 0.39
DNPEP Q9ULA0 1/20 0.39
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
PAOX Q6QHF9 2/20 0.37
KDM4C Q9H3R0 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
KDM4A O75164 1/20 0.37
PHF8 Q9UPP1 1/20 0.37
KDM2A Q9Y2K7 1/20 0.37
ADRA1A P35348 1/20 0.36
DPP7 Q9UHL4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8608292 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL1412121 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503562 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503728 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503552 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503614 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503740 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503583 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL20503602 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP
SCHEMBL3993428 1.00 KDM4E (0.43) KDM4EMAPK1HIF1AEPHX1ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180333345-A1 NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2018-11-22 US claimed
EP-3377547-A1 ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF ISP Investments LLC (US) 2018-09-26 EP claimed
US-20230210728-A1 ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF KURARAY NORITAKE DENTAL INC. (JP) 2023-07-06 US disclosed
US-10632059-B2 Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof ISP INVESTMENTS LLC (US) 2020-04-28 US disclosed
US-20180333345-A1 NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2018-11-22 US disclosed
EP-3377547-A1 ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF ISP Investments LLC (US) 2018-09-26 EP disclosed
US-8835368-B2 Compounds and a method of lubricating an internal combustion engine THE LUBRIZOL CORPORATION (US) 2014-09-16 US disclosed
US-20120065110-A1 Compounds and a Method of Lubricating an Internal Combustion Engine THE LUBRIZOL CORPORATION (US) 2012-03-15 US disclosed
EP-0777692-B1 PAPER-SIZING AGENTS CONTAINING AQUEOUS, SOLVENT-FREE DISPERSIONS OF CATIONIC POLYMERS AND METHOD OF PREPARING SIZED PAPER BY USING THESE AGENTS STOCKHAUSEN CHEM FAB GMBH (DE) 1998-04-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10632059-B2 Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof C9, PARG, C5 KDM4E 3623/4885MAPK1 4106/4885HIF1A 4528/4885
US-20230210728-A1 ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF KIT, SETD7, SETDB1 KDM4E 65/4885MAPK1 2456/4885HIF1A 3097/4885
US-20180333345-A1 NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF C9, C5, C1S KDM4E 3810/4885MAPK1 3724/4885HIF1A 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.